<DOC>
	<DOCNO>NCT03080129</DOCNO>
	<brief_summary>Protein-energy malnutrition ( PEM ) occur 65-90 % patient liver cirrhosis . Severity malnutrition correlate progression liver disease lead sarcopenia 30-70 % cirrhotic patient . Malnutrition sarcopenia associate increase risk complication mortality . In cirrhosis gut microbiome alter lead increase gut permeability , bacterial translocation inflammation . Since microbiome involve nutrient uptake metabolism , hypothesize microbiome alteration contribute sarcopenia . A prospective control cohort study investigate interrelation microbiome change sarcopenia cirrhosis conduct . Furthermore effect nutritional intervention microbiome cirrhosis study . From study information gut microbiome composition sarcopenia associate cirrhosis modulation gut microbiome nutritional intervention feasible collect .</brief_summary>
	<brief_title>Microbiome Sarcopenia Patients With Liver Cirrhosis</brief_title>
	<detailed_description>Scientific background Protein-energy malnutrition ( PEM ) occur 65-90 % patient chronic liver disease . PEM cause various factor include poor dietary intake , loss appetite , decrease hepatic protein synthesis , malabsorption hypermetabolism . It associate increase risk complication include ascites , hepatic encephalopathy , variceal bleeding , hepatorenal syndrome mortality . There direct relation progression liver disease severity malnutrition . Malnutrition sarcopenia liver cirrhosis patient PEM lead sarcopenia common , frequently overlook , complication . Sarcopenia define decrease muscle mass two standard deviation healthy young adult mean . Sarcopenia associate age , chronic disease malignancy . To determine severity muscle wasting , compute tomography scan ( CT ) magnetic resonance imaging ( MRI ) objective reproducible technique . Sarcopenia negatively impact survival , correlate risk infection , increase surgical risk lead poor quality life . Besides PEM also inflammation importance development sarcopenia . Diversity microbiome patient liver cirrhosis association sarcopenia . The gut microbiome liver cirrhosis patient alter compare healthy individual . Dysbiosis lead increase gut permeability , bacterial translocation inflammation . This contribute fibrogenesis may also related hepatocarcinogenesis . Hence , new treatment approach cirrhosis focus change microbial landscape . Modulation gut microbiome may also strategy reverse sarcopenia reduce systematic inflammation . Hypothesis aim There association gut microbiome composition , gut permeability existence sarcopenia cirrhotic patient . Primary hypothesis : Diversity gut microbiome reduce liver cirrhosis patient sarcopenia compare without sarcopenia healthy control . Secondary hypothesis : There association gut microbiome composition , biomarker gut permeability bacterial translocation presence sarcopenia cirrhosis . Oral nutrition supplement ( ONS ) influence composition gut microbiome , gut permeability , bacterial translocation inflammation . Aims : investigate : - composition gut microbiome - biomarkers gut permeability , bacterial translocation inflammation - incidence severity sarcopenia - impact oral nutrition supplement ( ONS ) gut microbiome</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Sarcopenia</mesh_term>
	<criteria>Hospitalized patient reason clinical/radiological/histological diagnosis cirrhosis Age &gt; 18y Informed consent CT/MRI scan within +/14 day baseline study visit Hepatic encephalopathy &gt; grade 2 cognitive disorder allow informed consent advance hepatocellular carcinoma Any condition circumstance , , opinion investigator , would affect patient 's ability participate protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Liver cirrhosis</keyword>
	<keyword>Sarcopenia</keyword>
	<keyword>Microbiome</keyword>
</DOC>